AURKA, an oncogene from the serine/threonine kinase family, is responsible for activating the process of cell division through mitosis regulation and promoting tumorigenesis and metastasis in different cancer types, and this property qualifies AURKA as a potential target in cancer treatment [33,34]. Here, MARK2 is linked to cancer.